SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending amidst intense speculation about an imminent executive order to reclassify cannabis to Schedule III, a move anticipated to significantly ease federal restrictions, improve financial operations, and attract institutional investment. The community is sharply divided between those expecting a massive short squeeze and price surge, and skeptics predicting a "sell the news" event or further dilution for the sector. This potential regulatory shift is seen as a pivotal moment for the entire cannabis industry, with many discussing its broad implications beyond just legalization.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Shares of DJT are trending amid a highly anticipated address from the company's namesake figure, sparking intense debate across the community. Perspectives are sharply divided, with some anticipating positive outcomes while others express skepticism over economic claims and forewarn further market volatility. The ongoing discourse is notably intertwined with broader political discussions and external events, including upcoming document releases, fueling active conversations among investors.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending after reporting strong earnings and exceptionally optimistic future guidance, primarily fueled by insatiable demand for its high-bandwidth memory (HBM) in the AI sector. The community is actively discussing that HBM supply is completely sold out through 2026, leading to expectations of significant analyst upgrades and broad belief in a multi-year growth cycle for the company. Many view this performance as a strong validation of underlying AI demand, especially given recent mixed signals from other tech companies.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending due to significant price declines and heightened investor anxiety surrounding its substantial debt, recent operational delays, and notable insider selling. The community is sharply divided, with many expressing concern over potential further downside and debt sustainability, while others view current price levels as a "buy the dip" opportunity, citing CoreWeave's impressive contractual backlog and strategic partnerships in the burgeoning AI space.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is experiencing heightened activity amid strong community anticipation for an imminent executive order to reclassify cannabis to Schedule III. This potential federal reform is seen as a game-changer, promising to eliminate onerous 280E taxes and pave the way for broader institutional investment, sparking widespread bullish sentiment for the US cannabis sector.

Medline, Inc. engages in the provision of medical-surgical products and supply chain solutions. It operates through the Medline Brand and Supply Chain Solutions segments. The Medline Brand segment is involved in the procurement and manufacture of products from surgical solutions, front line care, and laboratory and diagnostics categories. The Supply Chain Solutions segment focuses on procurement and distribution of a variety of third-party products from national brands and provides tailored logistics and supply chain optimization services to domestic and international consumers. The company was founded by Jim Mills and Jon Mills in 1966 and is headquartered in Northfield, IL.

Medline Inc - Ordinary Shares - Class A

Medline Inc.

MDLN is trending following its blockbuster market debut, which saw strong investor demand and a significant premium above its initial pricing. The community is actively discussing Medline's robust position as a leading medical supply giant, emphasizing its end-to-end supply chain control and financial health as key drivers for its long-term potential. This successful launch highlights investor confidence in the healthcare sector and marks a significant event for the broader IPO landscape.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending with an active community driving conversation around its identity as the 'culture coin' for the cannabis sector, often linked to the Solana ecosystem. Enthusiasts are actively touting its potential, humorously stating it's 'Like Bitcoin but way higher,' amidst discussions that also acknowledge its speculative nature.

AABG Token

AABBG Crypto is trending as investors eagerly await further updates on its new silver-backed cryptocurrency, AABBS, and the revamped AABB Wallet. The community is actively discussing the company's mining asset expansion and significant gold and silver holdings, especially amid rising precious metal valuations. This creates ongoing conversation around short volume activity and perceived market manipulation.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is trending due to robust demand for high-capacity data storage, fueled by the expanding AI and cloud computing sectors, which has driven impressive financial results and multiple analyst upgrades. The community is actively discussing whether its substantial rally is sustainable or if the stock is poised for a pullback, especially ahead of its upcoming inclusion in the Nasdaq-100 Index.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. (SOC) is trending due to a recent federal ruling designating its pipeline an interstate facility, effectively shifting regulatory authority from California to federal oversight. This development has ignited community discussions, with many anticipating a potential workaround to past permit denials and a significant short squeeze, while others remain cautious given previous regulatory hurdles.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

5AM Venture Management LLC Reduces Stock Holdings in Enliven Therapeutics, Inc. $ELVN

5AM Venture Management LLC reduced its stake in shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN - Free Report) by 41.6% in the 2nd quarter, according to the company in its most recent 13F filing...

Enliven Therapeutics (NASDAQ:ELVN) COO Anish Patel Sells 6,663 Shares of Stock

Enliven Therapeutics, Inc. (NASDAQ:ELVN - Get Free Report) COO Anish Patel sold 6,663 shares of the stock in a transaction that occurred on Monday, December 8th. The shares were sold at an average...

Enliven Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

Enliven Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules Enliven Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules PR Newswire BOULDER...

Enliven Therapeutics (NASDAQ:ELVN) Shares Down 6.5% Following Insider Selling

Enliven Therapeutics (NASDAQ:ELVN) Shares Down 6.5% on Insider Selling...

Insider Selling: Enliven Therapeutics (NASDAQ:ELVN) COO Sells 6,663 Shares of Stock

Enliven Therapeutics, Inc. (NASDAQ:ELVN - Get Free Report) COO Anish Patel sold 6,663 shares of the company's stock in a transaction on Monday, December 8th. The stock was sold at an average price of...

Enliven Therapeutics Announces New CEO to Drive Next Phase of Development

Enliven Therapeutics Announces New CEO to Drive Next Phase of Development Enliven Therapeutics Announces New CEO to Drive Next Phase of Development PR Newswire BOULDER, Colo., Dec. 11, 2025 Rick...

Enliven Therapeutics (NASDAQ:ELVN) Sees Unusually-High Trading Volume - Here's What Happened

Enliven Therapeutics (NASDAQ:ELVN) Sees Strong Trading Volume - Time to Buy...

Enliven Therapeutics, Inc. (NASDAQ:ELVN) Receives Average Rating of "Moderate Buy" from Brokerages

Enliven Therapeutics, Inc. (NASDAQ:ELVN - Get Free Report) has received an average rating of "Moderate Buy" from the six research firms that are presently covering the company, Marketbeat reports...

Wall Street Analysts Believe Enliven Therapeutics, Inc. (ELVN) Could Rally 101.26%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 101.3% in Enliven Therapeutics, Inc. (ELVN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Enliven Therapeutics (NASDAQ:ELVN) Shares Down 8% - Time to Sell?

Enliven Therapeutics (NASDAQ:ELVN) Stock Price Down 8% - Should You Sell...

Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of small molecule therapeutics. Its pipeline includes BCR-ABL Program: ELVN-001and HER2 Program: ELVN-002. The company was founded by Samuel S. Kintz, Joseph P. Lyssikatos, and Anish Patel on June 1, 2019 and is headquartered in Boulder, CO.

Enliven Therapeutics Inc

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

Current Price	$16.02
Prev Close	$16.91
Open	$16.95
Dividend Yield	0.00%
50-Day Moving Average	$20.55
Beta	1.40
Avg. Volume	660,406.84
PE Ratio	-8.68

52-Week High	$25.37
52-Week Low	$13.30
Market Capitalization	$1B
EPS (Annual)	-$1.89
Price to Book	1.99
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

ELVN
Enliven Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ELVN News

ELVNEnliven Therapeutics Inc